查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1750667

全球神经血管内线圈市场：市场规模、份额、趋势分析（按类型、应用、最终用途和地区）、细分市场预测（2025 年至 2030 年）

Neuroendovascular Coil Market Size, Share & Trends Analysis Report By Type, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

神经血管内线圈市场规模与趋势：

预计 2024 年全球神经血管内线圈市场规模将达到 10.4 亿美元，2025 年至 2030 年的复合年增长率为 6.5%。

这种增长是由于与人口老化和高血压、吸烟和糖尿病等生活方式相关的风险因素导致脑动脉瘤和中风发病率不断上升。

技术进步显着提高了此手术的有效性和安全性，包括新一代可拆卸、水凝胶涂层和3D复合弹簧圈的开发。根据美国国立卫生研究院（NIH）2025年的数据，美国每年约有79.5万人中风，其中约61万人为首次中风。近四分之一的中风倖存者会再次中风。在所有中风病例中，约87%被归类为缺血性中风，其余13%为出血性中风。

由于老年族群中动脉瘤等神经系统疾病的发生率较高，老化社会是神经血管内线圈市场的主要驱动力。随着老年人口的增长，对神经血管内线圈栓塞术等微创治疗的需求也随之增长，因为这些治疗比传统手术更安全，恢復速度也更快。此外，老年患者发生动脉瘤破裂和中风等併发症的风险更高，这进一步增加了对神经血管内线圈的需求。全球医疗保健系统正在适应老龄化社会的需求，增加治疗资源并提供优惠的报销政策，这有助于市场扩张。此外，对改善老年人生活品质的关注也推动了对神经血管内线圈等先进微创治疗方案的需求，从而促进了市场的成长。

下图显示了2050年经合组织国家65岁及以上人口的预测比例，凸显了全球老化趋势。预计韩国（39.8%）、日本（37.7%）和义大利（33.7%）等国家的老龄人口比例将最高，这表明由于预期寿命延长和出生率下降，人口结构正在快速变化。此外，随着人口老化，中风等疾病的发病率预计将上升，这意味着对与老龄化相关的医疗干预措施和技术（例如神经血管内弹簧圈）的需求将增加。

高血压是各种血管疾病最重要的危险因子之一，包括脑动脉瘤、中风和其他脑血管异常。其在世界各地的日益普及是推动神经血管内弹簧圈市场扩张的关键因素。神经血管内弹簧圈广泛用于治疗因未控制的高血压引起或加重的脑动脉瘤和血管畸形。高血压是出血性中风的主要原因。高血压会导致动脉变窄和硬化，使其更容易阻塞和破裂。包括使用弹簧圈在内的神经血管内治疗方法是治疗方法。根据英国心臟基金会 (BHF) (2025) 的数据，估计英国约有 30% 的成年人（约 1,600 万人）患有高血压，其中高达一半的人未接受有效治疗。虽然约有 1,100 万人已由全科医生确诊，但研究结果表明，可能仍有多达 500 万成年人未被诊断。总合，英国可能有多达 800 万人患有未确诊或未控制的高血压。

脑动脉瘤是由于血管变弱并形成膨胀而发生的，是老化社会面临的重大问题。动脉瘤的风险随着年龄增加而增加，尤其是在50岁以后。随着全球老年人口的增加，动脉瘤的发生率也随之上升，对治疗方案的需求也随之增加。神经血管内弹簧圈是治疗这些动脉瘤的首选方法之一，其侵入性比传统手术更小，因此非常适合有其他健康问题或不适合进行侵入性手术的老年患者。

目录

第一章 分析方法与范围

第二章执行摘要

3. 神经血管内线圈市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
    • 市场机会分析
    • 市场问题分析
  • 商业环境分析
    • 产业分析：波特五力分析
    • PESTEL分析

第四章神经血管内线圈市场：按类型分類的业务分析

  • 按类型分類的市场占有率（2024 年和 2030 年）
  • 按类型分類的仪表板
  • 按类型分類的市场规模预测和趋势分析（2018-2030）
  • 白金裸线圈
  • 水凝胶涂层弹簧圈

第五章神经血管内线圈市场：按应用分類的业务分析

  • 按应用分類的市场占有率（2024 年和 2030 年）
  • 特定于应用程式的仪表板
  • 按应用分類的市场规模预测和趋势分析（2018-2030）
  • 中风
  • 脑动脉瘤
  • 动静脉畸形（AVM）
  • 其他的

6. 神经血管内线圈市场：依最终用途分類的业务分析

  • 按最终用途分類的市场占有率（2024 年和 2030 年）
  • 最终用途仪表板
  • 按最终用途分類的市场规模预测和趋势分析（2018-2030 年）
  • 医院
  • 门诊手术中心
  • 专科诊所
  • 其他的

7. 神经血管内线圈市场：区域估计和趋势分析（按技术和最终用途）

  • 各地区市场占有率（2024 年及 2030 年）
  • 市场仪表板：按地区
  • 市场规模预测及趋势分析（2018-2030年）
  • 北美洲
    • 按国家/地区（2018-2030 年）
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 按国家/地区（2018-2030 年）
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 按国家/地区（2018-2030 年）
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 按国家/地区（2018-2030 年）
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 按国家/地区（2018-2030 年）
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争态势

  • 参与企业概况
  • 企业市场占有率分析（2024年）
  • 公司分类
  • 战略地图
  • 公司简介/上市公司
    • Penumbra, Inc
    • TERUMO CORPORATION
    • Kaneka Medical Europe NV
    • Stryker
    • Lepu Medical Technology（Beijing）Co.,Ltd
    • Balt
    • NeuroSafe Medical Co., Ltd.
    • Johnson &Johnson
    • Boston Scientific Corporation
    • Medtronic
Product Code: GVR-4-68040-577-1

Neuroendovascular Coil Market Size & Trends:

The global neuroendovascular coil market size was estimated at USD 1.04 billion in 2024 and is projected to grow at a CAGR of 6.5% from 2025 to 2030. This growth is attributed to the increasing incidence of cerebral aneurysms and strokes, fueled by aging populations and lifestyle-related risk factors such as hypertension, smoking, and diabetes.

Technological advancements have significantly enhanced procedural efficacy and safety, including developing next-generation detachable, hydrogel-coated, and 3D complex coils. According to the data by NIH 2025, each year, an estimated 795,000 people in the U.S. experience a stroke, with approximately 610,000 of these being first-time occurrences. Nearly one in four stroke survivors will suffer a subsequent stroke. Among all stroke cases, about 87% are classified as ischemic strokes, while the remaining 13% are hemorrhagic strokes.

The aging population significantly drives the neuroendovascular coil market due to the higher prevalence of neurological conditions, such as aneurysms, which are more common in older adults. As the elderly population grows, the demand for minimally invasive treatments, such as neuroendovascular coil embolization, increases, as these procedures are safer and involve quicker recovery than traditional surgery. Additionally, the higher risk of complications in older patients, such as aneurysms bursting or strokes, further boosts the demand for neuroendovascular coils. Healthcare systems worldwide are adapting to the needs of aging populations, increasing treatment resources, and creating favorable reimbursement policies, which helps expand the market. Moreover, the focus on improving the quality of life for elderly individuals enhances the demand for advanced, minimally invasive options such as neuroendovascular coils, contributing to the market's growth.

The below graph presents projected data on the proportion of the population aged 65 and older across various OECD countries by the year 2050, highlighting the global trend of population aging. Countries such as South Korea (39.8%), Japan (37.7%), and Italy (33.7%) are expected to have the highest percentages of elderly individuals, indicating rapid demographic shifts driven by increased life expectancy and declining birth rates. Additionally, it indicates a growing demand for age-related medical interventions and technologies, such as neuroendovascular coils, as the incidence of conditions such as stroke is expected to rise with the aging demographic.

Hypertension is one of the most significant risk factors for a variety of vascular diseases, including cerebral aneurysms, strokes, and other cerebrovascular abnormalities. Its growing prevalence globally is a critical factor driving the expansion of the neuroendovascular coil market. Neuroendovascular coils are widely used in the treatment of brain aneurysms and vascular malformations, which are caused or exacerbated by uncontrolled hypertension. Hypertension is the leading cause of hemorrhagic strokes. It contributes to the narrowing and hardening of arteries, making them more susceptible to blockage or rupture. Neuroendovascular procedures, including the use of coils, are a frontline treatment for hemorrhagic strokes caused by ruptured aneurysms. The increasing global burden of hypertension, especially in low- and middle-income countries where blood pressure control is insufficient, is expected to lead to a rise in stroke cases, thereby propelling the demand for neuroendovascular interventions. According to the British Heart Foundation BHF, 2025, it is estimated that around 30% of UK adults, approximately 16 million people, are living with high blood pressure, and up to half of them are not receiving effective treatment. While about 11 million individuals have been diagnosed by their general practitioner, this suggests that up to 5 million adults may remain undiagnosed. In total, up to 8 million people in the UK could be living with undiagnosed or uncontrolled high blood pressure.

Aneurysms in the brain, which occur when blood vessels weaken and form a bulge, are a significant concern among the aging population. The risk of aneurysms increases with age, particularly after age 50. As the number of elderly individuals rises globally, the occurrence of aneurysms has become more prevalent, fueling demand for treatment options. Neuroendovascular coils are one of the preferred methods for treating these aneurysms, as they involve less invasive techniques than traditional surgery, making them more suitable for elderly patients who may have other health concerns or are not candidates for more invasive procedures.

Global Neuroendovascular Coil Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global neuroendovascular coil market report based on type, application, end use, and region:

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Bare Platinum Coils
  • Hydrogel-Coated Coils
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Cerebral Infarction
  • Cerebral Aneurysm
  • Arteriovenous Malformation (AVM)
  • Others
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Ambulatory Surgery Centers
  • Specialty Clinics
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Neuroendovascular Coil Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising incidence of cerebral aneurysms and stroke
      • 3.2.1.2. Growing preference for minimally invasive procedures
      • 3.2.1.3. Technological advancements in coil design
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of devices and procedures
      • 3.2.2.2. Risk of recurrence or incomplete occlusion
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Expansion in emerging markets
    • 3.2.4. Market Challenges Analysis
      • 3.2.4.1. Regulatory and clinical trial complexities
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Neuroendovascular Coil Market: Type Business Analysis

  • 4.1. Type Market Share, 2024 & 2030
  • 4.2. Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Bare Platinum Coils
    • 4.4.1. Bare Platinum Coils Market, 2018 - 2030 (USD Million)
  • 4.5. Hydrogel-Coated Coils
    • 4.5.1. Hydrogel-Coated Coils Market, 2018 - 2030 (USD Million)

Chapter 5. Neuroendovascular Coil Market: Application Business Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Cerebral Infarction
    • 5.4.1. Cerebral Infarction Market, 2018 - 2030 (USD Million)
  • 5.5. Cerebral Aneurysm
    • 5.5.1. Cerebral Aneurysm Market, 2018 - 2030 (USD Million)
  • 5.6. Arteriovenous Malformation (AVM)
    • 5.6.1. Arteriovenous Malformation (AVM) Market, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Neuroendovascular Coil Market: End Use Business Analysis

  • 6.1. End Use Market Share, 2024 & 2030
  • 6.2. End Use Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospital
    • 6.4.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 6.5. Ambulatory Surgery Centers
    • 6.5.1. Ambulatory Surgery Centers Market, 2018 - 2030 (USD Million)
  • 6.6. Specialty Clinics
    • 6.6.1. Specialty Clinics Market, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Neuroendovascular Coil Market: Regional Estimates & Trend Analysis by Technology and End Use

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America Neuroendovascular Coil Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework
      • 7.4.2.3. Competitive Insights
      • 7.4.2.4. U.S. Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework
      • 7.4.3.3. Competitive Insights
      • 7.4.3.4. Canada Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory Framework
      • 7.4.4.3. Competitive Insights
      • 7.4.4.4. Mexico Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Neuroendovascular Coil Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework
      • 7.5.2.3. Competitive Insights
      • 7.5.2.4. UK Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework
      • 7.5.3.3. Competitive Insights
      • 7.5.3.4. Germany Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework
      • 7.5.4.3. Competitive Insights
      • 7.5.4.4. France Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework
      • 7.5.5.3. Competitive Insights
      • 7.5.5.4. Italy Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework
      • 7.5.6.3. Competitive Insights
      • 7.5.6.4. Spain Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework
      • 7.5.7.3. Competitive Insights
      • 7.5.7.4. Norway Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework
      • 7.5.8.3. Competitive Insights
      • 7.5.8.4. Denmark Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Sweden
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Regulatory Framework
      • 7.5.9.3. Competitive Insights
      • 7.5.9.4. Sweden Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Neuroendovascular Coil Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework
      • 7.6.2.3. Competitive Insights
      • 7.6.2.4. Japan Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework
      • 7.6.3.3. Competitive Insights
      • 7.6.3.4. China Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework
      • 7.6.4.3. Competitive Insights
      • 7.6.4.4. India Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework
      • 7.6.5.3. Competitive Insights
      • 7.6.5.4. South Korea Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework
      • 7.6.6.3. Competitive Insights
      • 7.6.6.4. Australia Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Framework
      • 7.6.7.3. Competitive Insights
      • 7.6.7.4. Thailand Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Neuroendovascular Coil Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework
      • 7.7.2.3. Competitive Insights
      • 7.7.2.4. Brazil Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Framework
      • 7.7.3.3. Competitive Insights
      • 7.7.3.4. Argentina Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Neuroendovascular Coil Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework
      • 7.8.2.3. Competitive Insights
      • 7.8.2.4. South Africa Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework
      • 7.8.3.3. Competitive Insights
      • 7.8.3.4. Saudi Arabia Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework
      • 7.8.4.3. Competitive Insights
      • 7.8.4.4. UAE Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Regulatory Framework
      • 7.8.5.3. Competitive Insights
      • 7.8.5.4. Kuwait Neuroendovascular Coil Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Share Analysis, 2024
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Penumbra, Inc
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. TERUMO CORPORATION
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Kaneka Medical Europe N.V.
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Stryker
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Lepu Medical Technology (Beijing) Co.,Ltd
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Balt
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. NeuroSafe Medical Co., Ltd.
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Johnson & Johnson
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Boston Scientific Corporation
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Medtronic
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global neuroendovascular coil market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 5 Global neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 7 North America neuroendovascular coil market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 9 North America neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 10 North America neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 11 U.S. neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 12 U.S. neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 13 U.S. neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 14 Canada neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 15 Canada neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Canada neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 17 Mexico neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 18 Mexico neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Mexico neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 20 Europe neuroendovascular coil market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 22 Europe neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Europe neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 24 UK neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 25 UK neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 26 UK neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 27 Germany neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 28 Germany neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Germany neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 30 France neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 31 France neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 32 France neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 33 Italy neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 34 Italy neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Italy neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 36 Spain neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 37 Spain neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Spain neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 39 Norway neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 40 Norway neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Norway neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 42 Denmark neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 43 Denmark neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Denmark neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 45 Sweden neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 46 Sweden neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Sweden neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific neuroendovascular coil market, by country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Japan neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 53 Japan neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Japan neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 55 China neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 56 China neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 57 China neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 58 India neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 59 India neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 60 India neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 61 Australia neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 62 Australia neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Australia neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 64 South Korea neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 65 South Korea neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 66 South Korea neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 67 Thailand neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 68 Thailand neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Thailand neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 70 Latin America neuroendovascular coil market, by country, 2018 - 2030 (USD Million)
  • Table 71 Latin America neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 72 Latin America neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Latin America neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 74 Brazil neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 75 Brazil neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Brazil neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 77 Argentina neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 78 Argentina neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 79 Argentina neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Neuroendovascular coil market, by country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 84 South Africa neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 85 South Africa neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 86 South Africa neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 90 UAE neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 91 UAE neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 92 UAE neuroendovascular coil market, by application, 2018 - 2030 (USD Million)
  • Table 93 Kuwait neuroendovascular coil market, by type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait neuroendovascular coil market, by end use, 2018 - 2030 (USD Million)
  • Table 95 Kuwait neuroendovascular coil market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Neuroendovascular coil market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Type and application outlook (USD Million)
  • Fig. 10 End use outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 Neuroendovascular coil market dynamics
  • Fig. 13 Neuroendovascular coil market: Porter's five forces analysis
  • Fig. 14 Neuroendovascular coil market: PESTLE analysis
  • Fig. 15 Neuroendovascular coil market: Type segment dashboard
  • Fig. 16 Neuroendovascular coil market: Type market share analysis, 2024 & 2030
  • Fig. 17 Bare platinum coils market, 2018 - 2030 (USD Million)
  • Fig. 18 Hydrogel-coated coils market, 2018 - 2030 (USD Million)
  • Fig. 19 Neuroendovascular coil market: Application segment dashboard
  • Fig. 20 Neuroendovascular coil market: Application market share analysis, 2024 & 2030
  • Fig. 21 Cerebral infarction market, 2018 - 2030 (USD Million)
  • Fig. 22 Cerebral aneurysm market, 2018 - 2030 (USD Million)
  • Fig. 23 Arteriovenous Malformation (AVM) market, 2018 - 2030 (USD Million)
  • Fig. 24 Neuroendovascular coil market: End use segment dashboard
  • Fig. 25 Neuroendovascular coil market: End use market share analysis, 2024 & 2030
  • Fig. 26 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 27 Ambulatory surgery centers market, 2018 - 2030 (USD Million)
  • Fig. 28 Specialty clinics market, 2018 - 2030 (USD Million)
  • Fig. 29 Others market, 2018 - 2030 (USD Million)
  • Fig. 30 Neuroendovascular coil market revenue, by region
  • Fig. 31 Regional marketplace: Key takeaways
  • Fig. 32 Regional marketplace: Key takeaways
  • Fig. 33 North America neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. country dynamics
  • Fig. 35 U.S. neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 36 Canada country dynamics
  • Fig. 37 Canada neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 38 Mexico country dynamics
  • Fig. 39 Mexico neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 40 Europe neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 41 UK country dynamics
  • Fig. 42 UK neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 43 Germany country dynamics
  • Fig. 44 Germany neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 45 France country dynamics
  • Fig. 46 France neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 47 Italy country dynamics
  • Fig. 48 Italy neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 49 Spain country dynamics
  • Fig. 50 Spain neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 51 Norway country dynamics
  • Fig. 52 Norway neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 53 Sweden country dynamics
  • Fig. 54 Sweden neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 55 Denmark country dynamics
  • Fig. 56 Denmark neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 57 Asia Pacific neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 58 Japan country dynamics
  • Fig. 59 Japan neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 60 China country dynamics
  • Fig. 61 China neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 62 India country dynamics
  • Fig. 63 India neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 64 Australia country dynamics
  • Fig. 65 Australia neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 66 South Korea country dynamics
  • Fig. 67 South Korea neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 68 Thailand country dynamics
  • Fig. 69 Thailand neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 70 Latin America neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 71 Brazil country dynamics
  • Fig. 72 Brazil neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 73 Argentina country dynamics
  • Fig. 74 Argentina neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 75 MEA neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 76 South Africa country dynamics
  • Fig. 77 South Africa neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 78 Saudi Arabia country dynamics
  • Fig. 79 Saudi Arabia neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 80 UAE country dynamics
  • Fig. 81 UAE neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 82 Kuwait country dynamics
  • Fig. 83 Kuwait neuroendovascular coil market, 2018 - 2030 (USD Million)
  • Fig. 84 Company categorization
  • Fig. 85 Company share analysis, 2024
  • Fig. 86 Strategic framework